ESTOP IV

Main information

  • Trade name:
  • ESTOP IV V.
  • Composition:
  • V.
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • ESTOP IV V.
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

20-3-2018

FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy

FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy

FDA approves Adcetris (brentuximab vedotin) to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy

FDA - U.S. Food and Drug Administration

22-2-2018

February 21, 2018: Pharmacy Tech Sentenced to Five Years in Prison for Tampering with Opioids for IV Fluid

February 21, 2018: Pharmacy Tech Sentenced to Five Years in Prison for Tampering with Opioids for IV Fluid

February 21, 2018: Pharmacy Tech Sentenced to Five Years in Prison for Tampering with Opioids for IV Fluid

FDA - U.S. Food and Drug Administration

16-1-2018

FDA Commissioner Scott Gottlieb, M.D., updates on some ongoing shortages related to IV fluids

FDA Commissioner Scott Gottlieb, M.D., updates on some ongoing shortages related to IV fluids

FDA updates on some ongoing shortages related to IV fluids

FDA - U.S. Food and Drug Administration

4-1-2018

Statement by FDA Commissioner Scott Gottlieb, M.D., update on recovery efforts in Puerto Rico, and continued efforts to mitigate IV saline and amino acid drug shortages

Statement by FDA Commissioner Scott Gottlieb, M.D., update on recovery efforts in Puerto Rico, and continued efforts to mitigate IV saline and amino acid drug shortages

Statement by FDA Commissioner Scott Gottlieb, M.D., update on recovery efforts in Puerto Rico, and continued efforts to mitigate IV saline and amino acid drug shortages

FDA - U.S. Food and Drug Administration

20-12-2017

Pantoprazole Sodium for Injection 40 Mg Per Vial: Recall - Presence of Glass Particles

Pantoprazole Sodium for Injection 40 Mg Per Vial: Recall - Presence of Glass Particles

Administration of a glass particulate may result in local irritation or swelling in response to the foreign material. More serious potential outcomes would include blockage and clotting in blood vessels, which may be life-threatening.

FDA - U.S. Food and Drug Administration

19-12-2017

AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Pantoprazole Sodium for Injection 40 Mg Per Vial, Due to Presence of Glass Particles in the Vial.

AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Pantoprazole Sodium for Injection 40 Mg Per Vial, Due to Presence of Glass Particles in the Vial.

East Windsor, New Jersey, AuroMedics Pharma LLC is voluntarily recalling one lot of Pantoprazole Sodium for Injection 40 mg per vial, to the hospital level. The product was found to contain glass particles in the vial. This problem was discovered as a result of a product complaint in which the contents of one vial from one batch was found to contain a piece of glass.

FDA - U.S. Food and Drug Administration

11-12-2017

FDA Drug Safety Communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning

FDA Drug Safety Communication: FDA warns of increased risk of death with IV antibacterial Tygacil (tigecycline) and approves new Boxed Warning

This update is in follow-up to the FDA Drug Safety Communication: Increased risk of death with Tygacil (tigecycline) compared to other antibiotics used to treat similar infections issued on September 1, 2010.

FDA - U.S. Food and Drug Administration

30-11-2017

Statement by FDA Commissioner Scott Gottlieb, M.D., updating on Puerto Rico related medical product shortages

Statement by FDA Commissioner Scott Gottlieb, M.D., updating on Puerto Rico related medical product shortages

Statement by FDA Commissioner Scott Gottlieb, M.D. on efforts by the agency to address the impact of IV saline products and amino acids for injection shortages following the hurricane and update on FDA’s work in Puerto Rico

FDA - U.S. Food and Drug Administration

17-11-2017

Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls

Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls

Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts by the agency to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls

FDA - U.S. Food and Drug Administration

12-4-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Unit Dose Services]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Unit Dose Services]

Updated Date: Apr 12, 2018 EST

US - DailyMed

28-3-2018

CARDENE IV (Nicardipine Hydrochloride) Injection, Solution [Chiesi USA, Inc.]

CARDENE IV (Nicardipine Hydrochloride) Injection, Solution [Chiesi USA, Inc.]

Updated Date: Mar 28, 2018 EST

US - DailyMed

22-3-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [McKesson Corporation]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [McKesson Corporation]

Updated Date: Mar 22, 2018 EST

US - DailyMed

8-3-2018

Potentially Unsafe Prescribing Common in Patients With CKD

Potentially Unsafe Prescribing Common in Patients With CKD

Almost half of patients with stage III/IV chronic kidney disease (CKD) were prescribed one or more relatively contraindicated medications, and more than a third were prescribed nonsteroidal anti-inflammatory drugs (NSAIDs), a study found.

US - RxList

1-3-2018

There May Be a Better IV Fluid Than Saline, Studies Find

There May Be a Better IV Fluid Than Saline, Studies Find

Title: There May Be a Better IV Fluid Than Saline, Studies FindCategory: Health NewsCreated: 2/28/2018 12:00:00 AMLast Editorial Review: 2/28/2018 12:00:00 AM

US - MedicineNet

1-3-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Major Pharmaceuticals]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Major Pharmaceuticals]

Updated Date: Mar 1, 2018 EST

US - DailyMed

26-2-2018

EU/3/18/1973 (ProQR Therapeutics IV BV)

EU/3/18/1973 (ProQR Therapeutics IV BV)

EU/3/18/1973 (Active substance: 2'-O-(2-methoxyethyl)-modified antisense oligonucleotide targeting exon 13 in the USH2A gene) - Orphan designation - Commission Decision (2018)1241 of Mon, 26 Feb 2018 European Medicines Agency (EMA) procedure number: EMA/OD/197/17

Europe -DG Health and Food Safety

23-2-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Aurobindo Pharma Limited]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Aurobindo Pharma Limited]

Updated Date: Feb 23, 2018 EST

US - DailyMed

21-2-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Cardinal Health]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Cardinal Health]

Updated Date: Feb 21, 2018 EST

US - DailyMed

20-2-2018

PANTOPRAZOLE SODIUM (Pantoprazole) Tablet, Delayed Release [Proficient Rx LP]

PANTOPRAZOLE SODIUM (Pantoprazole) Tablet, Delayed Release [Proficient Rx LP]

Updated Date: Feb 20, 2018 EST

US - DailyMed

16-2-2018

Stage IV Colon Cancer That Has Spread to the Liver

Stage IV Colon Cancer That Has Spread to the Liver

Title: Stage IV Colon Cancer That Has Spread to the LiverCategory: Doctor's & Expert's views on SymptomsCreated: 7/5/2016 12:00:00 AMLast Editorial Review: 2/16/2018 12:00:00 AM

US - MedicineNet

8-2-2018

Protonix vs. Prilosec

Protonix vs. Prilosec

Protonix (pantoprazole sodium) and Prilosec (omeprazole) are proton pump inhibitors (PPIs) used to treat gastroesophageal reflux disease (GERD) and a history of erosive esophagitis. Prilosec is also used to treat ulcers and frequent heartburn. Protonix is available by prescription while Prilosec is available over-the-counter (OTC) and as a generic.

US - RxList

8-2-2018

Protonix vs. Zantac

Protonix vs. Zantac

Protonix (pantoprazole sodium) and Zantac (ranitidine hydrochloride) are used to treat gastroesophageal reflux disease (GERD) and erosive esophagitis. Zantac is also used for treating heartburn and Zollinger-Ellison syndrome.

US - RxList

7-2-2018

Protonix vs. Dexilant

Protonix vs. Dexilant

Protonix (pantoprazole sodium) and Dexilant (dexlansoprazole) are proton pump inhibitors (PPIs) used to treat gastroesophageal reflux disease (GERD) and erosive esophagitis.

US - RxList

7-2-2018

Protonix vs. Nexium

Protonix vs. Nexium

Protonix (pantoprazole sodium) and Nexium (esomeprazole magnesium) are proton pump inhibitors (PPIs) to treat gastroesophageal reflux disease (GERD) and a history of erosive esophagitis in adult patients. Nexium is also used to treat stomach and duodenal ulcers and Zollinger-Ellison syndrome. Protonix is available by prescription while Nexium is available over-the-counter (OTC) and as a generic.

US - RxList

7-2-2018

Protonix vs. Pepcid

Protonix vs. Pepcid

Protonix (pantoprazole sodium) and Pepcid (famotidine) are used to treat gastroesophageal reflux disease (GERD) and erosive esophagitis. Pepcid is also used to treat and prevent recurrence of stomach and duodenal ulcers. Pepcid is also useful in managing heartburn and Zollinger-Ellison syndrome.

US - RxList

7-2-2018

Protonix vs. Prevacid

Protonix vs. Prevacid

Protonix (pantoprazole sodium) and Prevacid (lansoprazole) are proton pump inhibitors (PPIs) used to treat gastroesophageal reflux disease (GERD) and a history of erosive esophagitis. Prevacid is also used to treat and prevent stomach and intestinal ulcers and other conditions involving excessive stomach acid such as Zollinger-Ellison syndrome. Protonix is available by prescription while Prevacid is available over-the-counter (OTC) and as a generic.

US - RxList

7-2-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Mylan Pharmaceuticals Inc.]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Mylan Pharmaceuticals Inc.]

Updated Date: Feb 7, 2018 EST

US - DailyMed

6-2-2018

Protonix vs. Aciphex

Protonix vs. Aciphex

Protonix (pantoprazole sodium) and Aciphex (rabeprazole sodium) are proton pump inhibitors (PPIs) used to treat gastroesophageal reflux disease (GERD) and erosive esophagitis. Aciphex is also used to treat duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori (H. pylori) bacterial infections in the stomach.

US - RxList

1-2-2018

'IV Lounges' Are the Latest Health Fad, But Are They Safe?

'IV Lounges' Are the Latest Health Fad, But Are They Safe?

Title: 'IV Lounges' Are the Latest Health Fad, But Are They Safe?Category: Health NewsCreated: 1/31/2018 12:00:00 AMLast Editorial Review: 1/31/2018 12:00:00 AM

US - MedicineNet

31-1-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Legacy Pharmaceutical Packaging, LLC]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Legacy Pharmaceutical Packaging, LLC]

Updated Date: Jan 31, 2018 EST

US - DailyMed

31-1-2018

MERREM IV (Meropenem) Injection [AstraZeneca Pharmaceuticals LP]

MERREM IV (Meropenem) Injection [AstraZeneca Pharmaceuticals LP]

Updated Date: Jan 31, 2018 EST

US - DailyMed

30-1-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [AvKARE, Inc.]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [AvKARE, Inc.]

Updated Date: Jan 30, 2018 EST

US - DailyMed

30-1-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Teva Pharmaceuticals USA, Inc.]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Teva Pharmaceuticals USA, Inc.]

Updated Date: Jan 30, 2018 EST

US - DailyMed

29-1-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Macleods Pharmaceuticals Limited]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Macleods Pharmaceuticals Limited]

Updated Date: Jan 29, 2018 EST

US - DailyMed

25-1-2018

PANTOPRAZOLE Tablet, Delayed Release [Dr.Reddy'S Laboratories Limited]

PANTOPRAZOLE Tablet, Delayed Release [Dr.Reddy'S Laboratories Limited]

Updated Date: Jan 25, 2018 EST

US - DailyMed

19-1-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Clinical Solutions Wholesale, LLC]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Clinical Solutions Wholesale, LLC]

Updated Date: Jan 19, 2018 EST

US - DailyMed

18-1-2018

Flu Intensity, IV Bag Shortage Have Hospitals Scrambling

Flu Intensity, IV Bag Shortage Have Hospitals Scrambling

The combination of a severe flu season and reduced supplies of intravenous (IV) fluid bags after Hurricane Maria devastated manufacturing plants in Puerto Rico has hospital teams strategizing on alternatives.

US - RxList

18-1-2018

Flu Intensity, IV Bag Shortage

Flu Intensity, IV Bag Shortage

Flu Intensity, IV Bag Shortage Have Hospitals Scrambling

US - eMedicineHealth

10-1-2018

Succinylcholine

Succinylcholine

Succinylcholine is a skeletal muscle relaxant for intravenous (IV) administration indicated as an adjunct to general anesthesia.

US - RxList

4-1-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [California Pharmaceutical, LLC]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [California Pharmaceutical, LLC]

Updated Date: Jan 4, 2018 EST

US - DailyMed

2-1-2018

PANTOPRAZOLE SODIUM Tablet, Delayed Release [RPK Pharmaceuticals, Inc.]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [RPK Pharmaceuticals, Inc.]

Updated Date: Jan 2, 2018 EST

US - DailyMed

28-12-2017

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Northwind Pharmaceuticals]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Northwind Pharmaceuticals]

Updated Date: Dec 28, 2017 EST

US - DailyMed

27-12-2017

Norvasc vs. Tenormin

Norvasc vs. Tenormin

Norvasc (amlodipine) and Tenormin (atenolol) (and Tenormin IV) are used for the prevention and treatment of heart pain or chest pain from angina, and for the treatment of high blood pressure (hypertension).

US - RxList

27-12-2017

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Preferred Pharmaceuticals Inc.]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Preferred Pharmaceuticals Inc.]

Updated Date: Dec 27, 2017 EST

US - DailyMed

27-12-2017

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Wockhardt USA LLC.]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Wockhardt USA LLC.]

Updated Date: Dec 27, 2017 EST

US - DailyMed

21-12-2017

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Proficient Rx LP]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Proficient Rx LP]

Updated Date: Dec 21, 2017 EST

US - DailyMed

11-12-2017

PANTOPRAZOLE SODIUM Tablet, Delayed Release [A-S Medication Solutions]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [A-S Medication Solutions]

Updated Date: Dec 11, 2017 EST

US - DailyMed

8-12-2017

CATEGORY IV (Immune System Booster) Liquid [Vitality Works, Inc.]

CATEGORY IV (Immune System Booster) Liquid [Vitality Works, Inc.]

Updated Date: Dec 8, 2017 EST

US - DailyMed

21-11-2017

PANTOPRAZOLE SODIUM (Pantoprazole Sodium) Tablet, Delayed Release [REMEDYREPACK INC.]

PANTOPRAZOLE SODIUM (Pantoprazole Sodium) Tablet, Delayed Release [REMEDYREPACK INC.]

Updated Date: Nov 21, 2017 EST

US - DailyMed

13-11-2017

PANTOPRAZOLE SODIUM Tablet, Delayed Release [St. Mary'S Medical Park Pharmacy]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [St. Mary'S Medical Park Pharmacy]

Updated Date: Nov 13, 2017 EST

US - DailyMed

30-10-2017

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Preferred Pharmaceuticals, Inc.]

PANTOPRAZOLE SODIUM Tablet, Delayed Release [Preferred Pharmaceuticals, Inc.]

Updated Date: Oct 30, 2017 EST

US - DailyMed

26-10-2017

PANTOPRAZOLE SODIUM (Pantoprazole) Tablet, Delayed Release [Amneal Pharmaceuticals LLC]

PANTOPRAZOLE SODIUM (Pantoprazole) Tablet, Delayed Release [Amneal Pharmaceuticals LLC]

Updated Date: Oct 26, 2017 EST

US - DailyMed